nDatalyze provides operational and RTO update.
CALGARY, AB – September 2, 2026 – nDatalyze Corp. (CSE: NDAT) (OTC: NDATF) (the “Company” or “nDatalyze”) updates RTO and EpitomePD Hockey application status.
EpitomePD Hockey application – https://www.epitomepd.com/
The company’s marketing person, Nicholas Domitrovic, has recently accepted a playing position with a European hockey team and has been replaced by D’Arcy Funfer who has assumed the role of National Sales Director. D’Arcy, an experienced sales and marketing professional who has worked with the Company in the past in an investor relations capacity, will focus on market penetration as the new hockey season unfolds.
Reverse Takeover (“RTO”) Update
The Company remains committed to completing its previously announced reverse takeover transaction (the “RTO”) with PRISM Diversified Ltd. (https://www.prismdiversified.com/) which closing date has been extended to October 31, 2026. The extension was provided largely to accommodate timing issues related to the necessary shareholder approvals. The Company’s special shareholders meeting is to be held on October 2, 2026.
About nDatalyze Corp.
nDatalyze Corp. is a technology company focused on developing health and performance-related solutions through the application of advanced artificial intelligence and biometric data analytics.
For Further Information, please contact:
Jim Durward, President, CEO/CTO
Email: jimd@ndatalyze.com
Tel: (403) 689-3901
nDatalyze Website: https://www.ndatalyze.com
Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release. This news release does not constitute an offer to sell or a solicitation of an offer to sell any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available. The information in this news release includes certain information and statements about management’s view of future events, expectations, plans and prospects that constitute forward looking statements. These statements are based upon assumptions that are subject to significant risks and uncertainties. Because of these risks and uncertainties and as a result of a variety of factors, the actual results, expectations, achievements or performance may differ materially from those anticipated and indicated by these forward-looking statements. Any number of factors could cause actual results to differ materially from these forward-looking statements as well as future results. Although the Corporation believes that the expectations reflected in forward looking statements are reasonable, it can give no assurances that the expectations of any forward-looking statements will prove to be correct. Except as required by law, the Corporation disclaims any intention and assumes no obligation to update or revise any forward-looking statements to reflect actual results, whether as a result of new information, future events, changes in assumptions, changes in factors affecting such forward-looking statements or otherwise.